Join to View Full Profile
1500 E Medical Center DrFl UnivAnn Arbor, MI 48109
Phone+1 734-936-4300
Dr. Wahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganResidency, Radiation Oncology, 2012 - 2017
St Joseph Mercy Ann ArborInternship, Transitional Year, 2012 - 2013
University of Michigan Medical SchoolClass of 2012
Certifications & Licensure
MI State Medical License 2017 - 2027
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.Yupei Guo, Zian Li, Leslie A Parsels, Zhuwen Wang, Joshua D Parsels
Neuro-Oncology. 2025-04-10 - Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment.Kelly C Paradis, Charles Mayo, Charles K Matrosic, Joann I Prisciandaro, Benjamin S Rosen
International Journal of Radiation Oncology, Biology, Physics. 2025-03-09 - A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly ...Michelle M Kim, Madhava P Aryal, Krithika Suresh, Benjamin S Rosen, Hemant Parmar
International Journal of Radiation Oncology, Biology, Physics. 2025-03-08
Journal Articles
- No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence, Clinical Cancer Research
Press Mentions
Small Lab Leans on Integrity to Become Nationally-Recognized Phenotyping CenterJune 8th, 2021- Rackham Student Raises over $80,000 for University of Michigan NeurosurgeonMarch 15th, 2021
Can Patient-Derived Xenografts Predict Treatment Responses in Glioblastoma?July 18th, 2019- Join now to see all
Grant Support
- Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.WASHINGTON UNIVERSITY2022–2027
- Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.WASHINGTON UNIVERSITY2022–2027
- Targeting Nucleotide Metabolism to Overcome Therapy Resistance in GlioblastomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
